Serum zinc levels and Alzheimer's disease

L. L. Rulon, J. D. Robertson, M. A. Lovell, M. A. Deibel, W. D. Ehmann, W. R. Markesbery

Research output: Contribution to journalArticlepeer-review

65 Scopus citations


Concentrations of zinc in postmortem serum and four brain regions were measured by flame atomic absorption spectrometry and instrumental neutron activation analysis, respectively, in nine Alzheimer's disease (AD) and eight control subjects. A statistically significant elevation of zinc serum was observed in AD subjects (136.4 ± 66.8 μg/dL) compared with age-matched control subjects (71.1 ± 35.0 μg/dL). No significant differences were observed between AD and control zinc concentrations in the amygdala, hippocampus, cerebellum, and superior and middle temporal gryi.

Original languageEnglish
Pages (from-to)79-85
Number of pages7
JournalBiological Trace Element Research
Issue number1-3
StatePublished - 2000


  • Alzheimer's disease
  • Brain
  • FAAS
  • INAA
  • Serum
  • Zinc

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Clinical Biochemistry
  • Inorganic Chemistry
  • Biochemistry, medical


Dive into the research topics of 'Serum zinc levels and Alzheimer's disease'. Together they form a unique fingerprint.

Cite this